Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 149

1.

A cluster-randomized trial of mass drug administration with a gametocytocidal drug combination to interrupt malaria transmission in a low endemic area in Tanzania.

Shekalaghe SA, Drakeley C, van den Bosch S, ter Braak R, van den Bijllaardt W, Mwanziva C, Semvua S, Masokoto A, Mosha F, Teelen K, Hermsen R, Okell L, Gosling R, Sauerwein R, Bousema T.

Malar J. 2011 Aug 24;10:247. doi: 10.1186/1475-2875-10-247.

2.

Routine delivery of artemisinin-based combination treatment at fixed health facilities reduces malaria prevalence in Tanzania: an observational study.

Khatib RA, Skarbinski J, Njau JD, Goodman CA, Elling BF, Kahigwa E, Roberts JM, MacArthur JR, Gutman JR, Kabanywanyi AM, Smith EE, Somi MF, Lyimo T, Mwita A, Genton B, Tanner M, Mills A, Mshinda H, Bloland PB, Abdulla SM, Kachur SP.

Malar J. 2012 Apr 30;11:140. doi: 10.1186/1475-2875-11-140.

3.
4.

Primaquine clears submicroscopic Plasmodium falciparum gametocytes that persist after treatment with sulphadoxine-pyrimethamine and artesunate.

Shekalaghe S, Drakeley C, Gosling R, Ndaro A, van Meegeren M, Enevold A, Alifrangis M, Mosha F, Sauerwein R, Bousema T.

PLoS One. 2007 Oct 10;2(10):e1023.

5.

In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals.

Shekalaghe SA, ter Braak R, Daou M, Kavishe R, van den Bijllaardt W, van den Bosch S, Koenderink JB, Luty AJ, Whitty CJ, Drakeley C, Sauerwein RW, Bousema T.

Antimicrob Agents Chemother. 2010 May;54(5):1762-8. doi: 10.1128/AAC.01135-09. Epub 2010 Mar 1.

6.

Primaquine for reducing Plasmodium falciparum transmission.

Graves PM, Gelband H, Garner P.

Cochrane Database Syst Rev. 2012 Sep 12;(9):CD008152. doi: 10.1002/14651858.CD008152.pub2. Review. Update in: Cochrane Database Syst Rev. 2014;(6):CD008152.

PMID:
22972117
7.

The effect of mass administration of sulfadoxine-pyrimethamine combined with artesunate on malaria incidence: a double-blind, community-randomized, placebo-controlled trial in The Gambia.

von Seidlein L, Walraven G, Milligan PJ, Alexander N, Manneh F, Deen JL, Coleman R, Jawara M, Lindsay SW, Drakeley C, De Martin S, Olliaro P, Bennett S, Schim van der Loeff M, Okunoye K, Targett GA, McAdam KP, Doherty JF, Greenwood BM, Pinder M.

Trans R Soc Trop Med Hyg. 2003 Mar-Apr;97(2):217-25.

PMID:
14584381
8.

Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial.

von Seidlein L, Milligan P, Pinder M, Bojang K, Anyalebechi C, Gosling R, Coleman R, Ude JI, Sadiq A, Duraisingh M, Warhurst D, Alloueche A, Targett G, McAdam K, Greenwood B, Walraven G, Olliaro P, Doherty T.

Lancet. 2000 Jan 29;355(9201):352-7. Erratum in: Lancet 2000 Jun 10;355(9220):2080.

PMID:
10665554
9.

Efficacy of different primaquine-based antimalarial regimens against Plasmodium falciparum gametocytemia.

Arango EM, Upegui YA, Carmona-Fonseca J.

Acta Trop. 2012 May;122(2):177-82. doi: 10.1016/j.actatropica.2012.01.005. Epub 2012 Jan 8.

PMID:
22245668
10.

Randomized trial of piperaquine with sulfadoxine-pyrimethamine or dihydroartemisinin for malaria intermittent preventive treatment in children.

Cisse B, Cairns M, Faye E, NDiaye O, Faye B, Cames C, Cheng Y, NDiaye M, Lô AC, Simondon K, Trape JF, Faye O, NDiaye JL, Gaye O, Greenwood B, Milligan P.

PLoS One. 2009 Sep 28;4(9):e7164. doi: 10.1371/journal.pone.0007164.

11.
12.

Nonrandomized controlled trial of artesunate plus sulfadoxine-pyrimethamine with or without primaquine for preventing posttreatment circulation of Plasmodium falciparum gametocytes.

Shah NK, Schapira A, Juliano JJ, Srivastava B, MacDonald PD, Poole C, Anvikar A, Meshnick SR, Valecha N, Mishra N.

Antimicrob Agents Chemother. 2013 Jul;57(7):2948-54. doi: 10.1128/AAC.00139-13. Epub 2013 Apr 15.

13.

Artemisinin-based combination therapy does not measurably reduce human infectiousness to vectors in a setting of intense malaria transmission.

Huho BJ, Killeen GF, Ferguson HM, Tami A, Lengeler C, Charlwood JD, Kihonda A, Kihonda J, Kachur SP, Smith TA, Abdulla SM.

Malar J. 2012 Apr 18;11:118. doi: 10.1186/1475-2875-11-118.

14.

Defining Plasmodium falciparum treatment in South West Asia: a randomized trial comparing artesunate or primaquine combined with chloroquine or SP.

Kolaczinski K, Leslie T, Ali I, Durrani N, Lee S, Barends M, Beshir K, Ord R, Hallett R, Rowland M.

PLoS One. 2012;7(1):e28957. doi: 10.1371/journal.pone.0028957. Epub 2012 Jan 31.

15.

Mass drug administration for malaria.

Poirot E, Skarbinski J, Sinclair D, Kachur SP, Slutsker L, Hwang J.

Cochrane Database Syst Rev. 2013 Dec 9;(12):CD008846. doi: 10.1002/14651858.CD008846.pub2. Review.

16.
17.

Revisiting the circulation time of Plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs.

Bousema T, Okell L, Shekalaghe S, Griffin JT, Omar S, Sawa P, Sutherland C, Sauerwein R, Ghani AC, Drakeley C.

Malar J. 2010 May 24;9:136. doi: 10.1186/1475-2875-9-136.

18.
19.

Modelling the impact of artemisinin combination therapy and long-acting treatments on malaria transmission intensity.

Okell LC, Drakeley CJ, Bousema T, Whitty CJ, Ghani AC.

PLoS Med. 2008 Nov 25;5(11):e226; discussion e226. doi: 10.1371/journal.pmed.0050226.

20.

The Impact of Hotspot-Targeted Interventions on Malaria Transmission in Rachuonyo South District in the Western Kenyan Highlands: A Cluster-Randomized Controlled Trial.

Bousema T, Stresman G, Baidjoe AY, Bradley J, Knight P, Stone W, Osoti V, Makori E, Owaga C, Odongo W, China P, Shagari S, Doumbo OK, Sauerwein RW, Kariuki S, Drakeley C, Stevenson J, Cox J.

PLoS Med. 2016 Apr 12;13(4):e1001993. doi: 10.1371/journal.pmed.1001993. eCollection 2016 Apr.

Supplemental Content

Support Center